Studies show that serum biomarkers such as M2PK and carcinoembryonic antigen (CEA) and/or combinations of these biomarkers could be a promising primary screening test in mass CRC screening [1, 2] but larger prospective studies using study populations representing a screening population are needed to verify promising results [23]. Here, CEACAM5 is linked to colorectal carcinoma.